Active Surveillance for Low-Risk Cancer—The Waiting Is the Hardest Part
This Viewpoint describes the benefits and challenges of active surveillance as a clinical approach to monitor low-risk cancers with favorable prognoses.
Authors
- David A. Haggstrom (ORCID: https://orcid.org/0000-0003-3637-6950)
- Paul K. J. Han (ORCID: https://orcid.org/0000-0003-0165-1940)
- Signe M. Braafladt
Institutions
- Regenstrief Institute (US)
- Richard L. Roudebush VA Medical Center (US)
- National Cancer Institute (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2024-08-15
- DOI
- https://doi.org/10.1001/jamaoncol.2024.2667
- Primary Topic
- Health, Environment, Cognitive Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00